… To our knowledge, this is the first report on HIV/HCV dynamics with PEG-IFN treatment.
Although small, our data set may be helpful in designing new studies and individualized patient …

… with HIV/HCV coinfection undergo HCV treatment with the … approved for the treatment of
hepatitis C in HIV-infected patients … HIV cohort studies have provided strong evidence that HCV …

… the combination of IFN-a plus RBV is relatively well tolerated in HIV/HCV-coinfected patients.
The rate of treatment discontinuation found in this study (12%) is similar to that seen in HIV-…

… , HCV genotype, and the level of HCV viremia. Moreover, since the effect of IFN-a on HCV
… in terms of the rate of response to treatment in HIV-infected patients. Statistical analysis. We …

… In summary, HIV asymptomatic patients with chronic hepatitis C and patients with HCV but
without HIV infection are likely to respond to IFN-a treatment in a similar way. In the future a …

… [77] reported marked decreases in the absolute CD4 + cell counts in HIV-infected patients
with chronic hepatitis C treated with IFN. A similar observation was made in the APRICOT, …

… for chronic hepatitis C at our institution and had a minimum follow-up of 6 months … HCV
treatment modalities: IFN monotherapy, IFN plus ribavirin (RBV) or pegylated interferon (PEG-IFN…

… In our study PEG-IFN + RBV was significantly more effective than IFN + RBV for the treatment
of chronic hepatitis C in HIV co-infected patients. In concordance with published data in the …

… IFN-α and ribavirin to treat HCV infection among HIV-co-infected individuals, the close
monitoring of both HCV and HIV viral kinetics as well as IFN … of IFN against HCV and HIV. …

… of interferon cs (IFN ~) treatment of chronic hepatitis C in HIV-… hepatitis C were consecutively
enrolled and treated with IFN ~ … after cessation of treatment. Eight patients responded to …